Ghana Heart Initiative supports health facilities with medical equipment
The Ghana Heart Initiative (GHI), a GIZ project funded by Bayer AG, a pharmaceutical company, presented more than 313 pieces of medical equipment worth 200,000 euros to the Greater Regional Health Authority on Tuesday. Accra.
The equipment included 164 blood pressure monitors, 41 scales with altimeter, 43 glucometers, 32 EKGs, four monitors and 29 defibrillators.
They would be distributed among 44 beneficiary health facilities, including respectively the Ada Est and Lekma hospitals, as well as the Mamprobi polyclinic, which participate in the GHI pilot project in the Greater Accra region, for the prevention, diagnosis and management of diseases. cardiovascular disease (CVD).
Health Minister Kwaku Agyemang-Manu at the handover ceremony in Accra thanked GHI for the donation, saying it will support Ghana’s efforts to address the challenges posed by cardiovascular disease, which matters. among the leading causes of death in the country. .
He said the tools are very essential for improving CVD care in healthcare facilities, and particularly welcome the moment when these diseases have become a significant comorbidity in relation to the COVID-19 pandemic.
The ministry, he said, has followed all the activities planned under the Initiative with keen interest and does not take them for granted at all.
“We are therefore delighted to sign an addendum to the memorandum of understanding, which provides for the extension of the GHI to other regions of Ghana and also to replicate in-depth or specialized training in deep vein thrombosis for six other public hospitals in Ghana in the pilot’s suite in Kumasi. ,” he said.
He encouraged recipient institutions to take good care of the equipment and use it for its intended purpose, and to ensure proper and timely maintenance as required by policy to ensure its longevity.
GIZ Ghana Country Director Regina Bauerochse Barbosa said “Cardiovascular disease is a growing public health problem in Ghana and other African countries, adding that stroke and other cardiovascular disease has become a cause. major death due to increasing risk factors such as hypertension.
According to her, in sub-Saharan Africa, people at high risk of CVD were generally at the peak of their productive years, and that early diagnosis and proper management of risk factors and CVD could, however, reduce the fatal consequences.
She explained that it was to this end that GIZ had, since October 2018, facilitated the implementation of the GHI on behalf of Bayer AG, and in close cooperation with the Ghanaian Ministry of Health (MOH) and Ghana Health. Service (GHS). .
The Country Director thanked the Ministry of Health and the Ghana Health Service for their valuable cooperation since the implementation of the establishment of the GHI.
Mr. Clement Owusu-Addo, Bayer AG AWA Business Manager & Ghana Bureau Chief, said he saw it as his responsibility to help expand access to healthcare for all and was therefore proud to partner with the Ministry of Health, GHS, GIZ and the various health institutions in Ghana to strengthen health systems in order to be able to contribute to the fight against non-communicable diseases (NCDs), which continue to represent an increasing burden on Ghana.
He said that Bayer will continue to work closely with its partners to increase the effectiveness of treatment for NCDs in Ghana, while measuring the outcomes and impact of its efforts to increase patients’ access to healthcare, and “we will credibly monitor our impact through our partners and commit to reporting on our successes in a transparent and regular manner.
According to Dr Alfred Doku, director of the GHI project, heart disease and stroke were the leading causes of death among adult Ghanaians due to high blood pressure, which was largely undiagnosed and undertreated.
He said Ghana’s health system was not well placed to handle this situation, especially at the community level, so GHI support was aimed at strengthening the health system and facilitating detection, diagnosis and management of hypertension and other cardiovascular diseases.
He said that a successful implementation of the project would have a huge impact on the Ghanaian health system, saying that “by the end of 2021, 1,800 health professionals would have received training in assessment and monitoring. CVD risk management as well as basic care and advanced cardiac life. Support.
“So far, the GHI has already trained more than 650 health professionals and developed national guidelines for CVD management and a facilitator’s guide for CVD training, and as a result, 66 health facilities in the region of Greater Accra were already in a position to improve their management of CVD.
He said that at the end of the project, it was expected that more than 160 Ghanaian health facilities in all regions would benefit from the GHI, and mentioned other measures implemented such as the trial of a health center. 24/7 assistance calls for CVD management, improvement of cardiovascular disease data collection and management systems as well as direct Covid-19 support for two hospitals.
Dr Doku said together with the Ministry of Health and GHS, the project had successfully piloted in the Greater Accra region and was now being rolled out across the country.